Has Pfizer secured a global licensing deal for 3SBio’s cancer drug?
In a significant move, Pfizer has finalized a global licensing agreement with the Chinese biotech company 3SBio for their cancer drug, SSGJ-707. The deal, initially...
This website uses cookies to improve your experience. We assume you agree, but you can opt out if you wish. Accept More Info